Shareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights – GSKAccesswire • 02/28/25
GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights – GSKAccesswire • 02/28/25
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKAccesswire • 02/27/25
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of GSK plc (GSK) ShareholdersGlobeNewsWire • 02/26/25
GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of GSK plc to Contact the Firm Today!Accesswire • 02/26/25
GSK plc Class Action: Levi & Korsinsky Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 – GSKAccesswire • 02/26/25
GSK Securities Class Action: GSK PLC Investors Should Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the GSK Class Action LawsuitPRNewsWire • 02/26/25
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKGlobeNewsWire • 02/25/25
ROSEN, A LEADING NATIONAL FIRM, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKAccesswire • 02/20/25
The Gross Law Firm Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline – GSKGlobeNewsWire • 02/20/25
GSK plc Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmAccesswire • 02/20/25
Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)PRNewsWire • 02/20/25
ROSEN, LEADING INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSKAccesswire • 02/18/25
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for InvestorsBenzinga • 02/17/25
PENMENVY, GSK's 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWYBusiness Wire • 02/17/25
ROSEN, LEADING TRIAL ATTORNEYS, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKAccesswire • 02/15/25
Shareholder Rights Law Firm Robbins LLP Reminds GSK Investors with Large Losses to Seek Advice on Leading the GSK PLC Class ActionPRNewsWire • 02/15/25
Investors who Lost Money on GSK plc (GSK) Should Contact Levi & Korsinsky About Pending Class Action - GSKAccesswire • 02/14/25
India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugsReuters • 02/14/25